Dr. Thomas Serena, MD, FACS, FACHM, MAPWCA Has Agreed To Be MDM Wound Ventures, Inc’s Clinical And Research Director
Increases MDM Wound Ventures, Inc ability to develop and market additional innovative medical devices.
SAN ANTONIO, TX – (September 21, 2021) MDM Wound Ventures Inc., the manufacturer of EZDebride, is announcing Dr. Thomas Serena has agreed to the position of Clinical and Research Director at MDM Wound Ventures, Inc.
Dr. Thomas E. Serena MD FACS FACHM MAPWCA, Founder and Medical Director of The
SerenaGroup®, a family of wound, hyperbaric and research companies.
To date he has opened and operates wound care centers across the United Sates and globally. Dr. Serena has been the lead or Principal investigator in over 100 clinical trials, including gene therapy for critical limb ischemia, antimicrobial dressings, growth factors, topical and parenteral antibiotics and CTP therapy. He holds numerous patents on wound care devices and dressings. He is recognized internationally as an expert in the field of wound healing: He has more than 250 published papers and has given more than 2000 invited lectures throughout the world. He has been a member of the Board of Directors of the Wound Healing Society and served two terms on the board of the Association for the Advancement of Wound Care (AAWC) and is now Past-President. He has also been Vice-President of the American College of Hyperbaric Medicine and President of the American Professional Wound Care Association.
MDM Wound Ventures, Inc., develops and manufactures innovative and disruptive products for diabetic limb salvage and advanced wound care clinicians and providers, globally.
ABOUT EZ DEBRIDE
For more information about EZ Debride or MDM Wound Ventures Inc., or to book a clinical visit
and demonstration please contact:
EZ Debride / MDM Wound Ventures Inc
8800 Broadway St., #200
San Antonio, TX. 78217
888 884 7515
sales@mdmwoundventures.com
Recent Blogs
Dr. Thomas Serena, MD, FACS, FACHM, MAPWCA Has Agreed To Be MDM Wound Ventures, Inc’s Clinical And Research Director
September 21, 2021
Increases MDM Wound Ventures, Inc ability to develop and market additional innovative medical devices. SAN ANTONIO, TX – (September 21,…Read more
EZ Debride Is Soon Available In Singapore, Malaysia, Thailand, Indonesia, And Brunei
September 2, 2021
MDM Wound Ventures, Inc Signs A Distribution Agreement With Intega Healthcare. San Antonio, TX – EZ Debride, a registered and…Read more
EZ Debride Is Now Available In South Korea
September 1, 2021
MDM Wound Ventures, Inc Signs A Distribution Agreement With Uct Medical Co Ltd. MDM Wound Ventures, Inc Signs A Distribution…Read more
Dr. Thomas Serena, MD, F.A.C.S. to present EZ Debride clinical trial results at AAHCM Annual Meeting
June 9, 2020
EZ Debride clinical trial results at AAHCM Annual Meeting Thomas E. Serena M.D. F.A.C.S., founder and medical director of the…Read more
EZ Debride Signs Distribution Agreement with BMK Ventures
November 13, 2018
The agreement allows access to DoD, Federal Government and Veterans Administration Facilities. SCHERTZ, TX – (March 13, 2018) EZ Debride,…Read more
EZ Debride Launched First-Of-Its-Kind Medical Instrument At Wild on Wounds.
October 4, 2017
Sharp debridement tool has a revolutionary design that allows clinicians to debride like experts.* EZ Debride, a registered brand of…Read more
EZ Debride Receives Canadian Industrial Design Patent
September 18, 2017
EZ Debride was granted an Industrial Design Registration by Canada. “This is a big step for EZ Debride’s future North…Read more